Brief: Serina Therapeutics Says Submits IND To FDA, Receives HREC Approval In Australia For SER-252- SEC Filing
06/10/2025 22:58
Oct 6 (Reuters) - Serina Therapeutics Inc SER.A: SERINA THERAPEUTICS INC - SUBMITS IND TO FDA, RECEIVES HREC APPROVAL IN AUSTRALIA FOR SER-252 - SEC FILING Source text: [ID:n0001708599-25-000122] Further company coverage: SER.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Serina Therapeutics
See all newsBrief: Serina Therapeutics Inc Reports Cohort 1 Observations From Ser-252 Registrational Study In Advanced Parkinson’S Disease And Advances To Cohort 2
Brief: Serina Therapeutics - Offers Up To 12,500,000 Shares Of Common Stock By Roth Principal Investments - SEC Filing
Serina Therapeutics Q2 net loss widens on higher expenses
Brief: Serina Therapeutics Appoints Farrell Simon To Its Board Of Directors
Brief: Serina Therapeutics Completes Sentinel Dosing In Cohort 1 Of Phase 1B Registrational Trial Of SER-252